WXXWY:OTCMKTS
Wuxi Biologics Cayman ADR
12,48Â US$
arrow_downward
-0,68%(-0,085) 1D
19 tet, 12:46:13 m.d., GMT-4 · USD
search
Të gjitha simbolet
| Me simbole | Çmimi | Ndrysho | % ndryshim |
|---|
insights_autoPo gjenerohen statistikat kryesore për WXXWY...
Hap
12,19Â US$
I lartë
12,70Â US$
I ulët
12,19Â US$
Kapitalizimi i tregut
198,43Â mld
Vëllimi mesatar
64,29 mijë
Vëllimi
10,65 mijë
Maksimumi 52-javor
14,80Â US$
Minimumi 52-javor
7,30Â US$
Beta
0,01
Aksionet në qarkullim
2,06Â mld
Numri i punonjësve
15 mijë
Hap
12,19Â US$
I lartë
12,70Â US$
I ulët
12,19Â US$
Kapitalizimi i tregut
198,43Â mld
Vëllimi mesatar
64,29 mijë
Vëllimi
10,65 mijë
Maksimumi 52-javor
14,80Â US$
Minimumi 52-javor
7,30Â US$
Beta
0,01
Aksionet në qarkullim
2,06Â mld
Numri i punonjësve
15 mijë
Lajmet
Nga burimet në ueb dhe partnerët e lajmeve
Kalkine Media
·
24 minuta më parë
Is Canopy Growth (NASDAQ:CGC) Set To Benefit As Cannabis Reform Talk Heats Up?
Simply Wall Street
·
39 minuta më parë
Top Nuclear Stocks For October 2026
Hindustan Times
·
11 minuta më parë
S&P 500, Nasdaq rise as AI stocks rebound and oil prices ease ahead of major US company earnings this week | Hindustan Times
Profili
WuXi Biologics is a global Contract Research Development and Manufacturing Organization that provides open-access, integrated technology platforms for biologics drug development.
WuXi Biologics' roots date back to 2010, when it was founded as a division of WuXi AppTec and began building out capabilities and facilities required for biologics discovery, development and good manufacturing practices. After being spun off from its parent, WuXi Biologics went public on the Hong Kong Stock Exchange in June 2017.
As of 2021, WuXi Biologics has 18 manufacturing sites including ten in China, three in the United States, two in Ireland, two in Germany, and one in Singapore.
In August 2020, WuXi Biologics was selected to become a component of the Hang Seng Index in Hong Kong.
In January 2024, WuXi Biologics' share price fell on news that the United States Congress had introduced legislation to block any federal government contracts with the company due to national security concerns. The concerns stem from allegations, denied by the company, that it has worked closely with the People's Liberation Army as a part of the Chinese Communist Party's military-civil fusion strategy. Wikipedia
Rreth Wuxi Biologics Cayman ADR
Drejtori ekzekutivZhisheng Chen
Punonjësit14,7 mijë
Themeluar më2010
Selia-
SektoriHealth care
Uebsajtiwuxibiologics.com